Surgibay India Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 0.78 M
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.20 Cr
- Revenue Growth 107.21%
- Profit Growth 2.54%
- Ebitda -30.66%
- Net Worth 33.11%
- Total Assets 83.87%
About Surgibay India
Surgibay India Private Limited (SIPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 January 2016 (Nine years and one month 17 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.78 M.
The company currently has active open charges totaling ₹1.20 Cr.
Deepak Jha and Prabjyot Chopra serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74140GJ2016PTC085588
- Company No.
085588
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2016
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Surgibay India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Jha  | Director | 04-Jan-2016 | Current |
| Prabjyot Chopra | Director | 19-Dec-2019 | Current |
Financial Performance of Surgibay India.
Surgibay India Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 107.21% increase. The company also saw a slight improvement in profitability, with a 2.54% increase in profit. The company's net worth Soared by an impressive increase of 33.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surgibay India?
In 2019, Surgibay India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Origogens India Private LimitedDeepak Jha is a mutual person
Charges (Loans)
₹12.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 May 2016 | Others | ₹1.20 Cr | Open |
How Many Employees Work at Surgibay India?
Unlock and access historical data on people associated with Surgibay India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surgibay India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surgibay India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
